Description
SNS-314 is a selective and potent pan Aurora kinase inhibitor currently in a dose escalation phase 1 clinical trial for the treatment of patients with advanced solid tumors.
Product Overview
Aurora kinase inhibitor
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Molecular Formula
C18H15ClN6OS2
Chemical Name
1-(3-chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Download Datasheet